We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
- Authors
Ma, Li; Young, Jennifer; Prabhala, Harsha; Pan, Elizabeth; Mestdagh, Pieter; Muth, Daniel; Teruya-Feldstein, Julie; Reinhardt, Ferenc; Onder, Tamer T; Valastyan, Scott; Westermann, Frank; Speleman, Frank; Vandesompele, Jo; Weinberg, Robert A
- Abstract
MicroRNAs (miRNAs) are increasingly implicated in regulating the malignant progression of cancer. Here we show that miR-9, which is upregulated in breast cancer cells, directly targets CDH1, the E-cadherin-encoding messenger RNA, leading to increased cell motility and invasiveness. miR-9-mediated E-cadherin downregulation results in the activation of beta-catenin signalling, which contributes to upregulated expression of the gene encoding vascular endothelial growth factor (VEGF); this leads, in turn, to increased tumour angiogenesis. Overexpression of miR-9 in otherwise non-metastatic breast tumour cells enables these cells to form pulmonary micrometastases in mice. Conversely, inhibiting miR-9 by using a 'miRNA sponge' in highly malignant cells inhibits metastasis formation. Expression of miR-9 is activated by MYC and MYCN, both of which directly bind to the mir-9-3 locus. Significantly, in human cancers, miR-9 levels correlate with MYCN amplification, tumour grade and metastatic status. These findings uncover a regulatory and signalling pathway involving a metastasis-promoting miRNA that is predicted to directly target expression of the key metastasis-suppressing protein E-cadherin.
- Publication
Nature cell biology, 2010, Vol 12, Issue 3, p247
- ISSN
1476-4679
- Publication type
Journal Article
- DOI
10.1038/ncb2024